Skip to content
Review Open access

Integrating Enhanced Molecular Sampling, RNA-Specific Scoring Functions, and SILCS Technology for Small-Molecule Targeting of RNA

Sep 2026 · Journal of Chemical Theory and Computation · 1 citation · 109 references

TL;DR

An in silico method to facilitate RNA-targeting small-molecule discovery that integrates enhanced sampling molecular dynamics simulations using the classical Drude polarizable force field with site identification by ligand competitive saturation (SILCS) technology is developed.

Abstract

Increasing knowledge of the wide range of biological functions of ribonucleic acids (RNAs) has made them a critical target in drug development. Accordingly, modifying their function by targeting them with small, drug-like molecules for the development of therapeutic agents is attractive. However, the rational design of RNA-targeting small molecules has been hindered by the intrinsic structural complexity and dynamics of the RNAs. Here, we develop an in silico method to facilitate RNA-targeting small-molecule discovery that integrates enhanced sampling molecular dynamics (MD) simulations using the classical Drude polarizable force field with site identification by ligand competitive saturation (SILCS) technology. Enhanced sampling MD simulations initiated with apo RNA structures guided by reaction coordinates selected from order parameters identified through machine learning combined with survey data of ligand-bound structures of TAR RNA enable identification of druggable RNA conformations. Two custom RNA scoring functions are developed to (1) select RNA conformations with a high probability of containing druggable sites and (2) identify nucleotides comprising binding sites that are able to participate in interactions with small molecules. Subsequently, selected conformations are subjected to the SILCS method for the final selection of potential binding sites. Across three validation RNA systems, our method successfully identifies all experimentally known binding sites for four RNAs with both helical and noncanonical regions. In addition, novel potential binding sites were identified, supported by high-affinity SILCS FragMaps and docking analysis of FDA-approved ligands. However, only one of two binding sites in the THF riboswitch was identified, indicating limitations in the application of the method to RNAs with tertiary contacts. The developed method is anticipated to enable efficient virtual screening and lead optimization for RNA-targeted drug discovery.

Read PDF

Similar papers

#small language model Review Oct 2026

In silico designing of small molecules for targeting RNA: current landscape and future directions

The field’s persistent constraints, including lack of structural data, underdeveloped force fields, unresolved selectivity, and the gap between in silico and cellular activity, are examined, and the advances likely to narrow them are examined.

Akansha Pandit, Elagandhula Sathish, Omprakash Sharma et al. · 0 citations
Open access Sep 2026

HARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design

HARIBOSS++ is presented, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs and opens new avenues for biologists, bioinformaticians, and machine learning researchers to investigate RNA-SM interactions on a new scale.

Matteo Marengo, E. Chapeaublanc, Hervé Ménager et al. · 0 citations

MultiRSF: A Deep Learning Approach for Predicting RNA-Small-Molecule Binding Sites Using Surface Characteristics.

A multimodal deep learning framework that integrates molecular surface fingerprints, contextual sequence embeddings from a pretrained RNA language model and dot bracket secondary structure encoding to predict ligand binding sites on RNA, which provides an accurate and generalizable tool for nucleotide resolution bindin...

Jia-Sai Shu, Wen-Tao Xia, Ying-Jie Zheng et al. · 4 citations
Open access Sep 2026

DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities

DLRNA-BERTa is introduced, a RoBERTa-based framework that integrates RNA-BERTa and ChemBERTa-v2 to model molecule–RNA binding affinities and has potential utility for RNA-based drug repurposing and prioritization of candidate molecules for further investigation.

Pasquale Lobascio, Khalid Saeed, Asifullah Khan et al. · 0 citations
Review Open access Sep 2026

Small Activating RNAs: A Curated Database and an Overview of Rational Design Principles

RNA activation (RNAa), mediated by small activating RNAs (saRNAs), upregulates endogenous gene expression through recruitment of the Argonaute proteins to the promoter, natural antisense transcripts, or other noncoding RNAs. This mechanistically distinct modality addresses an unmet need, as few RNA therapeutics current...

Petra Sušjan-Leite, Peter Pečan, Ana Godeša et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.